Revvity Inc

NYSE:RVTYHealthcareCBOE:SPESGSTOXX:EDD24BP

$150.94−1.11%At closeAt close · Tue 20 Oct · ≈ AED 554.33 · Market cap $16.84B · Next earnings Mon 26 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	52.6%	59.6%	53.2%	48.1%	48.0%	53.1%	—	—
Operating margin	27.0%	35.0%	23.6%	14.5%	14.9%	12.5%	12.5%	+0.0 pts
Net margin	19.2%	24.6%	17.2%	−4.3%	10.7%	8.5%	8.5%	+0.0 pts
EBITDA margin	31.8%	42.2%	35.7%	25.9%	30.5%	23.2%	—	—
Return on equity	19.5%	13.2%	7.7%	−1.5%	3.9%	3.3%	3.3%	+0.0 pts
Return on assets	9.1%	6.3%	4.0%	−0.9%	2.4%	2.0%	2.0%	+0.0 pts
Return on capital employed	16.2%	9.7%	6.2%	3.3%	3.5%	3.3%	—	—
Debt / equity	0.6×	0.7×	0.6×	0.5×	0.4×	0.5×	0.5×	+0.0%
Debt / assets	27.9%	34.4%	32.5%	30.0%	26.8%	28.9%	—	—
Interest coverage	20.5×	13.1×	7.5×	4.0×	4.3×	3.9×	—	—
Current ratio	1.4×	2.0×	2.1×	2.1×	3.6×	1.7×	1.7×	+0.0%
Quick ratio	1.0×	1.7×	1.9×	1.8×	3.0×	1.4×	—	—
Cash ratio	0.2×	0.5×	0.3×	0.6×	1.8×	0.7×	0.7×	+0.0%
Asset turnover	0.5×	0.3×	0.2×	0.2×	0.2×	0.2×	—	—
Inventory turnover	3.5×	3.6×	3.8×	3.3×	3.9×	3.5×	—	—
Receivables turnover	3.3×	5.4×	5.4×	4.3×	4.4×	3.8×	—	—
Dividend payout	4.3%	3.4%	6.2%	−29.5%	11.6%	13.6%	—	—

Margins, returns, leverage and liquidityUpdated 28 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.